Respreeza 50 mg/ml à 1 g
Respreeza 50 mg/ml à 1 g is a medicine authorised by Swissmedic under authorisation number 65337. The authorisation holder is CSL Behring AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 January 2016 and the authorisation is valid without a time limit. ATC code B02AB02 places the medicine in the group Antihemorrhagics.
| Authorisation number | 65337 |
|---|---|
| Name | Respreeza 50 mg/ml à 1 g |
| Full name | Respreeza 50 mg/ml à 1 g, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung |
| Authorisation holder | CSL Behring AG |
| Medicinal product code | Blood products |
| Dispensing category | B · Prescription only |
| ATC code | B02AB02 |
| First authorisation | 21 January 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Respreeza 50 mg/ml à 1 g, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung | B | 21 January 2016 |
| 2 | Respreeza 50 mg/ml à 4 g, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung | B | 16 May 2019 |
| 3 | Respreeza 50 mg/ml à 5 g, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung | B | 16 May 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 2 | Durchstechflasche(n) | B02AB02 | 06.01.1. | B |
| 6 | 2 | Durchstechflasche(n) | B02AB02 | 06.01.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Respreeza 50 mg/ml à 1 g authorised in Switzerland?
Yes. Respreeza 50 mg/ml à 1 g is authorised by Swissmedic under authorisation number 65337, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Respreeza 50 mg/ml à 1 g have?
Respreeza 50 mg/ml à 1 g is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Respreeza 50 mg/ml à 1 g?
The authorisation holder is CSL Behring AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.